Enhancing the cell’s natural recycling center improves Alzheimer’s features in animal models
The findings suggest there is a possibility of translating these findings into therapy.
Read More
Alzheimer’s Disease
Image of the Month: Tau travels between neurons
This laboratory platform is a powerful way to study Alzheimer’s disease and other tau-caused conditions.
Read More
Redefining tubulin’s role in neurodegeneration: from passive casualty to active protector against disease
The findings suggest that modulating the tubulin pool could offer a selective therapeutic strategy.
Read More
Connecting the dots between cause-effect events in Alzheimer’s disease
This cross-species approach reveals that some paths seem to aggravate the disease while others may protect against it.
Read More
Research suggests that Alzheimer’s disease may develop through distinct biological pathways
This study analyzes fruit fly and human data to offer new insights into how Alzheimer’s disease risk genes affect the brain.
Read More
Brain “stars” hold the power to preserve cognitive function in model of Alzheimer’s disease
The findings suggest a potential astrocyte-based therapeutic approach to ameliorate cognitive decline in neurodegenerative disease.
Read More
Baylor researchers uncovered how physical activity helps improve memory in Alzheimer’s disease
The findings open new possibilities for future treatments to prevent or treat the condition.
Read More
An unexpected potential benefit of blood stem cells
Until now blood stem cell mutations have primarily been associated with promoting disease progression. This is the first time that these two mutations have been shown to influence disease in different ways.
Read More
Alzheimer’s disease affects an organism as a whole
The Alzheimer’s Disease Fly Cell Atlas may lead to a better understanding of the condition and improved treatments.
Read More
A combined computational and experimental approach uncovered promising genetic players in Alzheimer’s disease
This study provides solutions to the pressing need to identify factors that influence Alzheimer’s disease risk or resistance while offering a means explore potential biological markers and therapeutic targets.
Read More